DXCM vs STEM · P/E 63, rev $4.03B vs rev $144.6M
DexCom Inc (DXCM) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. STEM currently screens at market cap $82.1M.
Not investment advice. Open the DXCM and STEM stock pages for the full models.
Not investment advice.